RxDoctor Payments Data

Kamaneh Montazeri, MD

Hematology & Oncology · Boston, MANPI 1457766149

Payments from drug & device makers

$346,220in general payments, 2019–2025

Across 39 payments — averaging $8877.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trisalus Life Sciences, Inc.$264K
  • Merck$79K
  • Immunocore Limited$3K
  • AstraZeneca$43

What the payments were for

  • Consulting fees$1,00031%
  • Speaking & faculty fees$2,20068%
  • Education$431%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Trisalus Life Sciences, Inc.33$264,177
Merck1$78,800
Immunocore Limited4$3,200
AstraZeneca1$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$346,220 in reported general payments places this provider in the 70th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$42,507
Medicare patients
109
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →